FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012316077> ?p ?o ?g. }

• W2012316077 abstract "Regarding standardization of treatment, classification, and pathophysiology of peripheral T- and NK-cell neoplasias the current knowledge is markedly behind that of B-cell lymphomas, which are approximately 10 times more frequent. In May 2000, the study group 'Peripheral T- and NK-cell Neoplasias' was founded in Frankfurt/M. This group decided on a clinical protocol and a scientific program for research on the pathophysiology of these entities. Rationales for the therapeutic regimen are the efficacy of cyclophosphamide and doxorubicine as shown in protocols for treatment of high grade lymphoma, the synergism of cyclophosphamide and fludarabine, and reports demonstrating the efficacy of fludarabine in T-cell neoplasias.Patients will be treated with a combination of fludarabine (30 mg/m(2) days 1-3), cyclophosphamide (1000 mg/m(2) day 1) doxorubicine (25 mg/m(2) day 2+3) (FCD). For patients > or =65 years a dose-reduced FCD regimen will be administered. In patients included in the treatment study and additionally in patients with indolent disease not requiring therapy, scientific projects on the biology of peripheral T- and NK-cell neoplasias will be performed.Expected conclusions of the projected study are the establishment of treatment and diagnostic standards, and improvement of classification of these entities by clinical, morphologic and biologic parameters." @default.
• W2012316077 created "2016-06-24" @default.
• W2012316077 creator A5008256521 @default.
• W2012316077 creator A5010844781 @default.
• W2012316077 creator A5014095638 @default.
• W2012316077 creator A5018085687 @default.
• W2012316077 creator A5018156469 @default.
• W2012316077 creator A5046991493 @default.
• W2012316077 creator A5049195610 @default.
• W2012316077 creator A5049829923 @default.
• W2012316077 creator A5064196229 @default.
• W2012316077 creator A5066213019 @default.
• W2012316077 creator A5066284764 @default.
• W2012316077 creator A5084675513 @default.
• W2012316077 creator A5089180355 @default.
• W2012316077 creator A5089543959 @default.
• W2012316077 creator A5090007935 @default.
• W2012316077 date "2001-01-01" @default.
• W2012316077 modified "2023-09-26" @default.
• W2012316077 title "Treatment of Aggressive, or Progressing Indolent Peripheral T- and NK-Cell Neoplasias by Combination of Fludarabine, Cyclophosphamide and Doxorubicine" @default.
• W2012316077 cites W1548005039 @default.
• W2012316077 cites W1708475310 @default.
• W2012316077 cites W1733674927 @default.
• W2012316077 cites W1956149814 @default.
• W2012316077 cites W2033990350 @default.
• W2012316077 cites W2056647433 @default.
• W2012316077 cites W2077693320 @default.
• W2012316077 cites W2096393559 @default.
• W2012316077 cites W2096973035 @default.
• W2012316077 cites W2255549241 @default.
• W2012316077 cites W2318772898 @default.
• W2012316077 cites W81018373 @default.
• W2012316077 doi "https://doi.org/10.1159/000050305" @default.
• W2012316077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11441297" @default.
• W2012316077 hasPublicationYear "2001" @default.
• W2012316077 type Work @default.
• W2012316077 sameAs 2012316077 @default.
• W2012316077 citedByCount "7" @default.
• W2012316077 countsByYear W20123160772015 @default.
• W2012316077 crossrefType "journal-article" @default.
• W2012316077 hasAuthorship W2012316077A5008256521 @default.
• W2012316077 hasAuthorship W2012316077A5010844781 @default.
• W2012316077 hasAuthorship W2012316077A5014095638 @default.
• W2012316077 hasAuthorship W2012316077A5018085687 @default.
• W2012316077 hasAuthorship W2012316077A5018156469 @default.
• W2012316077 hasAuthorship W2012316077A5046991493 @default.
• W2012316077 hasAuthorship W2012316077A5049195610 @default.
• W2012316077 hasAuthorship W2012316077A5049829923 @default.
• W2012316077 hasAuthorship W2012316077A5064196229 @default.
• W2012316077 hasAuthorship W2012316077A5066213019 @default.
• W2012316077 hasAuthorship W2012316077A5066284764 @default.
• W2012316077 hasAuthorship W2012316077A5084675513 @default.
• W2012316077 hasAuthorship W2012316077A5089180355 @default.
• W2012316077 hasAuthorship W2012316077A5089543959 @default.
• W2012316077 hasAuthorship W2012316077A5090007935 @default.
• W2012316077 hasConcept C126322002 @default.
• W2012316077 hasConcept C143998085 @default.
• W2012316077 hasConcept C203014093 @default.
• W2012316077 hasConcept C2776694085 @default.
• W2012316077 hasConcept C2776755627 @default.
• W2012316077 hasConcept C2779263901 @default.
• W2012316077 hasConcept C2781413609 @default.
• W2012316077 hasConcept C71924100 @default.
• W2012316077 hasConcept C90924648 @default.
• W2012316077 hasConceptScore W2012316077C126322002 @default.
• W2012316077 hasConceptScore W2012316077C143998085 @default.
• W2012316077 hasConceptScore W2012316077C203014093 @default.
• W2012316077 hasConceptScore W2012316077C2776694085 @default.
• W2012316077 hasConceptScore W2012316077C2776755627 @default.
• W2012316077 hasConceptScore W2012316077C2779263901 @default.
• W2012316077 hasConceptScore W2012316077C2781413609 @default.
• W2012316077 hasConceptScore W2012316077C71924100 @default.
• W2012316077 hasConceptScore W2012316077C90924648 @default.
• W2012316077 hasLocation W20123160771 @default.
• W2012316077 hasLocation W20123160772 @default.
• W2012316077 hasOpenAccess W2012316077 @default.
• W2012316077 hasPrimaryLocation W20123160771 @default.
• W2012316077 hasRelatedWork W1544767211 @default.
• W2012316077 hasRelatedWork W168625184 @default.
• W2012316077 hasRelatedWork W1832881784 @default.
• W2012316077 hasRelatedWork W1910740057 @default.
• W2012316077 hasRelatedWork W1976189874 @default.
• W2012316077 hasRelatedWork W1998806243 @default.
• W2012316077 hasRelatedWork W2004961788 @default.
• W2012316077 hasRelatedWork W2057685381 @default.
• W2012316077 hasRelatedWork W2074643584 @default.
• W2012316077 hasRelatedWork W2089058554 @default.
• W2012316077 hasRelatedWork W2116180038 @default.
• W2012316077 hasRelatedWork W2138471558 @default.
• W2012316077 hasRelatedWork W2155235962 @default.
• W2012316077 hasRelatedWork W2160217770 @default.
• W2012316077 hasRelatedWork W2529840549 @default.
• W2012316077 hasRelatedWork W2530210815 @default.
• W2012316077 hasRelatedWork W2557592971 @default.
• W2012316077 hasRelatedWork W2572366962 @default.
• W2012316077 hasRelatedWork W2590605426 @default.
• W2012316077 hasRelatedWork W3093575130 @default.
• W2012316077 isParatext "false" @default.
• W2012316077 isRetracted "false" @default.
• W2012316077 magId "2012316077" @default.

• next